A Master Protocol Study of Orforglipron (LY3502970) in Participants With Hypertension and Obesity or Overweight (ATTAIN-Hypertension) GZL2
Clinical trial NCT06952530 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06952530
- Sponsor
- Eli Lilly and Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-30
- Primary completion
- 2027-09-01
- Enrollment
- 487
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.